Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review

Bibliographic Details
Title: Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review
Authors: Stéphanie Leroux, Françoise Mechinaud-Heloury, Evelyne Jacqz-Aigrain
Source: Frontiers in Pharmacology, Vol 12 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: paediatrics, malignancy, onco-hematology, glycopeptides, antifungals, population pharmacokinetics, Therapeutics. Pharmacology, RM1-950
More Details: The response to medications in children differs not only in comparison to adults but also between children of the different age groups and according to the disease. This is true for anti-infectives that are widely prescribed in children with malignancy. In the absence of pharmacokinetic/pharmacodynamic paediatric studies, dosage is frequently based on protocols adapted to adults. After a short presentation of the drugs, we reviewed the population pharmacokinetic studies available for glycopeptides (vancomycin and teicoplanin, n = 5) and antifungals (voriconazole, posaconazole, and amphotericin B, n = 9) currently administered in children with onco-hematological malignancies. For each of them, we reported the main study characteristics including identified covariates affecting pharmacokinetics and proposed paediatric dosage recommendations. This review highlighted the very limited amount of data available, the lack of consensus regarding PK/PD targets used for dosing optimization and regarding dosage recommendations when available. Additional PK studies are urgently needed in this specific patient population. In addition to pharmacokinetics, efficacy may be altered in immunocompromised patients and prospective clinical evaluation of new dosage regimen should be provided as they are missing in most cases.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.635345/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2021.635345
Access URL: https://doaj.org/article/485e817344c845308d4530df73b92fe4
Accession Number: edsdoj.485e817344c845308d4530df73b92fe4
Database: Directory of Open Access Journals
More Details
ISSN:16639812
DOI:10.3389/fphar.2021.635345
Published in:Frontiers in Pharmacology
Language:English